Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Dimethyl fumarate (Tecfidera) for multiple sclerosis.
Microcystic Macular Edema: Retrograde Maculopathy Caused by Optic Neuropathy.
Successful treatment of infliximab-associated immune-mediated sensory polyradiculopathy with intravenous immunoglobulin.
[The possibility of using music therapy in neurology on the example of multiple sclerosis].
Non pharmacological interventions for spasticity in multiple sclerosis.
Selective accumulation of pro-inflammatory T cells in the intestine contributes to the resistance to autoimmune demyelinating disease.
High salt drives Th17 responses in experimental autoimmune encephalomyelitis without impacting myeloid dendritic cells.
Mediation of Protection and Recovery From Experimental Autoimmune Encephalomyelitis by Macrophages Expressing the Human Voltage-Gated Sodium Channel NaV1.5.
Moxibustion for Asthma, Acupuncture for Epilepsy, Psychological Therapies for Irritable Bowel Syndrome, Exercise Training for Multiple Sclerosis, and Comfrey Root for Acute Back Pain.
Comprehensive analysis of human endogenous retrovirus group HERV-W locus transcription in multiple sclerosis brain lesions by high throughput amplicon sequencing.
Long-term safety of azathioprine therapy in multiple sclerosis.
Classification algorithms with multi-modal data fusion could accurately distinguish neuromyelitis optica from multiple sclerosis.
Prenylated Flavonoids from Cudrania tricuspidata Suppress Lipopolysaccharide-Induced Neuroinflammatory Activities in BV2 Microglial Cells.
Assessment of the Effect of Cigarette Smoking on Regional Brain Volumes and Lesion Load in Patients with Clinically Isolated Syndrome.
Diffusion tensor MRI as a biomarker in axonal and myelin damage.
Disseminated Encephalomyelitis-Like Central Nervous System Neoplasm in Childhood.
Fabry disease - underestimated in the differential diagnosis of multiple sclerosis?
Gamma-aminobutyric acid receptor agonists, aquaporin-4, and neuromyelitis optica: a potential link.
Progress in multiple sclerosis genetics.
Type I IFN receptor controls activated TYK2 in the nucleus: Implications for EAE therapy.
Pharmacogenomics strategies to optimize treatments for multiple sclerosis: Insights from clinical research.
EphB3 receptors function as dependence receptors to mediate oligodendrocyte cell death following contusive spinal cord injury.
Ocular Toxicities of MEK inhibitors and other targeted therapies.
Efficacy and safety of natalizumab treatment for relapsing-remitting multiple sclerosis: interim results of the tysabri(r) observational programme in the uk.
The Relationships Between Apathy and Executive Dysfunction in Multiple Sclerosis.

Pages